Intrinsic Pathway of Coagulation and Thrombosis: Insights From Animal Models. Issue 3 (March 2019)

• Record Type: Journal Article
• Authors: Grover, Steven P.; Mackman, Nigel
• Is Part Of: Arteriosclerosis, thrombosis, and vascular biology. Volume 39:Issue 3(2019)
• Publication Date: 2019-03
• Subjects: animals -- anticoagulants -- hemostasis -- thrombosis -- venous thrombosis; Arteriosclerosis -- Periodicals; Thrombosis -- Periodicals; Blood-vessels -- Pathophysiology -- Periodicals; Electronic journals; 616.13
• DOI: 10.1161/ATVBAHA.118.312130
• Languages: English
• ISSNs: 1079-5642

Abstract

Abstract : Activation of the intrinsic pathway of coagulation contributes to the pathogenesis of arterial and venous thrombosis. Critical insights into the involvement of intrinsic pathway factors have been derived from the study of gene-specific knockout animals and targeted inhibitors. Importantly, preclinical studies have indicated that targeting components of this pathway, including FXI (factor XI), FXII, and PKK (prekallikrein), reduces thrombosis with no significant effect on protective hemostatic pathways. This review highlights the advances made from studying the intrinsic pathway using gene-specific knockout animals and inhibitors in models of arterial and venous thrombosis. Development of inhibitors of activated FXI and FXII may reduce thrombosis with minimal increases in bleeding compared with current anticoagulant drugs.